Viscofan
Viscofan, S.A., together with its subsidiaries, manufactures, produces, and distributes casings in Spain, Rest of Europe, Middle East, Africa, Pacific Asia, North America, South America, and internationally. The company offers cellulose, collagen, fibrous, functional solutions, plastics, viscofan veggie, efan, edileaf, nutra-pharma collinstant, nutra-pharma satiscoll, and medical. It also provide… Read more
Viscofan (VIS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.068x
Based on the latest financial reports, Viscofan (VIS) has a cash flow conversion efficiency ratio of 0.068x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€62.04 Million) by net assets (€908.61 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Viscofan - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Viscofan's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Viscofan Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Viscofan ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NET ONE SYSTEMS
MU:NOX
|
N/A |
|
The Andersons Inc
NASDAQ:ANDE
|
-0.005x |
|
Smart REIT
PINK:CWYUF
|
0.020x |
|
TRIPLE FLAG PREC.MET.
F:3Y0
|
N/A |
|
Hillenbrand Inc
NYSE:HI
|
-0.019x |
|
Immunovant Inc
NASDAQ:IMVT
|
-0.094x |
|
Van Lanschot NV
AS:VLK
|
0.878x |
|
THK Co. Ltd
PINK:THKLF
|
0.025x |
Annual Cash Flow Conversion Efficiency for Viscofan (2004–2025)
The table below shows the annual cash flow conversion efficiency of Viscofan from 2004 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €937.48 Million | €188.43 Million | 0.201x | -19.97% |
| 2024-12-31 | €938.91 Million | €235.82 Million | 0.251x | +65.09% |
| 2023-12-31 | €957.77 Million | €145.71 Million | 0.152x | +14.28% |
| 2022-12-31 | €906.87 Million | €120.73 Million | 0.133x | -50.50% |
| 2021-12-31 | €822.78 Million | €221.30 Million | 0.269x | +11.04% |
| 2020-12-31 | €736.25 Million | €178.34 Million | 0.242x | +6.78% |
| 2019-12-31 | €784.37 Million | €177.93 Million | 0.227x | +37.20% |
| 2018-12-31 | €757.63 Million | €125.27 Million | 0.165x | -23.51% |
| 2017-12-31 | €727.68 Million | €157.29 Million | 0.216x | +8.92% |
| 2016-12-31 | €708.08 Million | €140.52 Million | 0.198x | -8.74% |
| 2015-12-31 | €633.20 Million | €137.70 Million | 0.217x | +5.84% |
| 2014-12-31 | €575.87 Million | €118.31 Million | 0.205x | -13.42% |
| 2013-12-31 | €521.62 Million | €123.78 Million | 0.237x | +13.53% |
| 2012-12-31 | €498.57 Million | €104.21 Million | 0.209x | -16.30% |
| 2011-12-31 | €449.44 Million | €112.24 Million | 0.250x | -18.51% |
| 2010-12-31 | €406.37 Million | €124.54 Million | 0.306x | -14.68% |
| 2009-12-31 | €345.21 Million | €123.99 Million | 0.359x | +95.01% |
| 2008-12-31 | €303.27 Million | €55.86 Million | 0.184x | -20.78% |
| 2007-12-31 | €295.81 Million | €68.78 Million | 0.233x | +81.76% |
| 2006-12-31 | €268.13 Million | €34.30 Million | 0.128x | -43.04% |
| 2005-12-31 | €251.77 Million | €56.54 Million | 0.225x | +22.10% |
| 2004-12-31 | €249.79 Million | €45.94 Million | 0.184x | -- |